|Bid||20.60 x 900|
|Ask||20.64 x 800|
|Day's range||20.48 - 21.31|
|52-week range||12.70 - 23.66|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||05 May 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||23.60|
LONDON and PHILADELPHIA , Nov. 7, 2019 /PRNewswire/ -- Clarivate Analytics Plc (NYSE: CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today ...
LONDON and PHILADELPHIA, Nov. 5, 2019 /PRNewswire/ -- OpSec Security, an Investcorp portfolio company and a global leader in anti-counterfeiting and brand protection solutions, and Clarivate Analytics plc (NYSE:CCC;CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced they have signed a definitive agreement whereby OpSec Security will acquire the MarkMonitor™ brand protection, antipiracy and antifraud business from Clarivate. Clarivate will retain the MarkMonitor Domain Management business.
Reaffirms Outlook for 2019 - Revenues $243.0 million , consistent on reported basis and up 0.4% at constant currency - Adjusted Revenues* $243.1 million , up 3.2% on reported basis and up 3.6% at constant ...
LONDON and PHILADELPHIA, Oct. 31, 2019 /PRNewswire/ -- Clarivate Analytics Plc ("Clarivate") (NYSE: CCC; CCC.WS) announced today the closing of its previously announced private offering of $700 million in aggregate principal amount of 4.50% Senior Secured Notes due 2026 (the "Notes") and its new $1.15 billion senior secured credit facility (the "Credit Facility"). The Notes were issued by Camelot Finance S.A., an indirect wholly-owned subsidiary of Clarivate, are secured on a first-lien pari passu basis with borrowings under the Credit Facility and are guaranteed on a joint and several basis by certain of Clarivate's subsidiaries. The Credit Facility consists of a $900 million term loan, fully drawn at closing, and a $250 million revolving credit facility, which was undrawn at closing.
LONDON and PHILADELPHIA, Oct. 22, 2019 /PRNewswire/ -- Clarivate Analytics Plc ("Clarivate") (NYSE: CCC, CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, announced today the commencement of a private offering of senior secured notes due 2026 (the "Notes"). The Notes are expected to be issued by Camelot Finance S.A., an indirect wholly-owned subsidiary of Clarivate, are expected to be secured on a first-lien pari passu basis with borrowings under a new senior secured credit facility, and are expected to be guaranteed on a joint and several basis by certain of Clarivate's subsidiaries. Clarivate intends to use the net proceeds from the offering, together with proceeds from the new senior secured credit facility, to refinance all amounts outstanding under its existing credit facility, to redeem its 7.875% Senior Notes due 2024 and pay fees and expenses related to the foregoing, and to fully fund its payment obligations under the agreement terminating its tax receivable agreement, as previously announced on August 22, 2019.
LONDON and PHILADELPHIA, Oct. 21, 2019 /PRNewswire/ -- Clarivate Analytics Plc (NYSE: CCC, CCC.WS) (the "Company" or "Clarivate"), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, will host an Investor Day conference in New York City on Tuesday, November 12. All are invited to listen to the event and view the presentation via webcast on the Clarivate Analytics Investor Relations website at http://ir.clarivate.com/. A replay will also be available as a webcast on the investor relations section of the Company's website.
LONDON, Oct. 16, 2019 /PRNewswire/ -- Today the Web of Science Group launched the enhanced Master Journal List, with new, improved functionality and a better user experience for the 320,000+ researchers, librarians and editors who visit the freely-available online list each month. The online list is the go-to place for researchers to explore which journals are included in the Web of Science, and to help them identify suitable publishing destinations for their research. Keith Collier, Vice President of Product Management, said: "We're proud of the Master Journal List, which is a completely free to use, definitive resource for journals in the Web of Science.
LONDON and PHILADELPHIA, Oct. 10, 2019 /PRNewswire/ -- The first large-scale survey on competitive research grant peer review, Grant Review in Focus, is published today by Publons, part of the Web of Science Group (a Clarivate Analytics company). A grant is a financial award given by a governmental body, non-profit, or private enterprise for a beneficial project of some kind, and the peer review of grant funding is a fundamental part of the research life cycle. Grant Review in Focus brings together the most extensive researcher survey on grant peer review ever conducted - with more than 4,500 respondents- and the full power of the Web of Science and InCites datasets.
LONDON and PHILADELPHIA , Oct. 8, 2019 /PRNewswire/ -- Clarivate Analytics Plc (NYSE: CCC, CCC.WS) (the "Company" or "Clarivate"), a global leader in providing trusted insights and ...
LONDON, Oct. 2 2019 /PRNewswire/ -- The Institute for Scientific Information at the Web of Science Group, a Clarivate Analytics company, today releases a new Global Research Report that reveals the untapped potential of the research base in South and East Asia. The report examines the research output of 14 countries* in S&E Asia, their levels of international collaboration, and research Impact Profiles using data from Web of Science.
CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced it has enhanced its well-established Integrity platform to support pharmaceutical companies' drug discovery and pre-clinical efforts. Currently trusted by 85% of the top 20 pharma companies globally, the modern, user-friendly application has been updated and rebranded as Cortellis Drug Discovery Intelligence. On average, pharma companies need to develop eight active substances for entry into Phase I clinical trials in order to bring just one to market.
Insights from the comprehensive report show there are two main factors in the pharmaceutical industry that are causing the increase in drug approvals and subsequently the decrease in cost per new molecular entity (NME). Of the 57 NMEs launched in 2018, 22 had an orphan drug designation, indicating that they targeted a rare disease. The second contributing factor is increased activity from smaller pharmaceutical companies.
-- 19 new Citation Laureates named, from seven countries -- To date, 50 Citation Laureates have gone on to receive a Nobel Prize, 29 within two years of being listed LONDON and PHILADELPHIA , Sept. 24, ...
LONDON, Sept. 19, 2019 /PRNewswire/ -- The Web of Science Group, a Clarivate Analytics company, is proud to announce that Springer Publishing Company, the innovative nursing, behavioral and health sciences, and medical publisher is moving its manuscript submission and peer review system to ScholarOne. The new agreement covers all of Springer Publishing Company's journals.
Cliff Greenberg, Senior Vice President and Portfolio Manager at Baron Funds SPACs can offer distinct advantages to institutional investors over traditional IPOs, including the ability to take a larger position early on at a reasonable price. That’s according to Cliff Greenberg, SVP and Portfolio Manager at Baron Funds, who participated in IPO Edge’s SPAC in Action! – a […]
LONDON, Sept. 17, 2019 /PRNewswire/ -- The Web of Science Group, a Clarivate Analytics company, today announced the winners of the Global Peer Review Awards, powered by Publons which recognize global researchers for both the quality and quantity of their peer reviews. Peer review is an often anonymous and unseen part of scholarly communications. Publons estimates that the top 1% of peer reviewers spent more than 1.32 million hours reviewing papers in 2018/19*.